Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arrow Pharmaceuticals is a leading Australian pharmaceutical company specializing in the development, marketing, and distribution of generic and branded medicines. Following its 2019 merger with Apotex Australia, the company became a cornerstone of Arrotex Pharmaceuticals, which is currently the largest generic pharmaceutical and private label over-the-counter provider in Australia. Arrow's extensive portfolio includes hundreds of products across diverse therapeutic areas such as cardiology, neurology, and oncology, aimed at providing affordable healthcare solutions. The company maintains a significant presence in the retail pharmacy sector, offering not only medications but also professional services and business support to community pharmacists. With a robust supply chain and a focus on high-volume essential medicines, Arrow plays a critical role in the Australian Pharmaceutical Benefits Scheme (PBS) landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arrow Pharma.